Dian Gu, PhD
Postdoctoral Scholar
Medicine
School of Medicine
Dian Gu is a postdoctoral fellow at Center for Tobacco Control Research and Education (CTCRE), UCSF. She received her PhD in Health Economics/Health Services Research from the University of Texas Health Science Center at Houston. Along with her PhD study, she was a PhD trainee in MD Anderson Cancer Center.
Show full bio (120 words) Hide full bio
In that role, she gained experience in applying health economics to cancer research, collaborating on manuscripts with clinicians on multiple projects concerned with cancer patients’ healthcare utilization, expenditures, and health outcomes. After finishing her PhD, she joined the Institute for Health & Aging at UCSF. In the work there, she mainly performed data analyses and collaborated on manuscripts with professors on a wide range of tobacco economics research projects. During the fellowship at CTCRE, Dian is interested in 1) estimating economic costs attributable to tobacco use of cancer and other tobacco-related illnesses; 2) examining the role of tobacco use in cancer prevention and development; 3) evaluating the economic impact of different tobacco control policies on vulnerable populations.
Education & Training
Show all (3) Hide
- MPH Behavioral Sciences and Health Education Emory University
- BS Public Health Administration Nanjing Medical University
- PHD Health Economics/Health Services Research The University of Texas
Interests
Show all (7) Hide
- Mental Health
- Health Disparity
- Chronic Disease
- Oncology
- Health Services Research
- Health Economics
- Tobacco Use
Grants and Projects
Show all (1) Hide
- Evaluation of a smoking cessation intervention for people experiencing homelessness, California Tobacco Related Diseases Research Program, 2023-2025
Publications (15)
Top publication keywords:
Cancer SurvivorsFertility PreservationVapingElectronic Nicotine Delivery SystemsDrug CostsMedication AdherenceCost ControlTobacco ProductsDepressionSEER ProgramBortezomibNeuroendocrine TumorsHealth ExpendituresMedicareSmall Cell Lung Carcinoma
-
Cost-effectiveness analysis of ovarian function preservation with GnRH agonist during chemotherapy in premenopausal women with early breast cancer.
Human reproduction (Oxford, England) 2023 Huang Y, Huang X, Huang X, Lin S, Luo S, Gu D, Weng X, Xu X -
Racial and sociodemographic predictors of COVID-19 compared with influenza, appendicitis, and all-cause hospitalization: retrospective cohort analysis.
Ethnicity & health 2023 Raphael E, Azar KMJ, Gu D, Shen Z, Rubinsky A, Wang M, Pantell M, Lyles CR, Fernandez A, Bibbins-Domingo K, Pressman A, Nasrallah C, Hamad R -
Association between e-cigarette use and food insecurity among low-income adults.
Tobacco control 2022 Gu D, Max WB, Yao T, Wang Y, Keeler C, Sung HY -
Cost-effectiveness of adding daratumumab or bortezomib to lenalidomide plus dexamethasone for newly diagnosed multiple myeloma.
Journal of managed care & specialty pharmacy 2021 Narsipur N, Bulla S, Yoo C, Do B, Tran K, Gu D, Zhong L, Wilson L -
The Association of California's Proposition 56 Tobacco Tax Increase With Smoking Behavior Across Racial and Ethnic Groups and by Income.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2021 Keeler C, Wang Y, Max W, Yao T, Gu D, Sung HY
Show all (10 more) Hide
-
First-Line Durvalumab in Addition to Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer: A U.S.-Based Cost-Effectiveness Analysis.
The oncologist 2021 Lin S, Luo S, Gu D, Li M, Rao X, Wang C, Huang P, Xu X, Weng X -
Prolonged Opioid Use After Surgery for Early-Stage Breast Cancer.
The oncologist 2020 Shen C, Thornton JD, Gu D, Dodge D, Zhou S, He W, Zhao H, Giordano SH -
Association between depression and healthcare expenditures among elderly cancer patients.
BMC psychiatry 2020 Gu D, Morgan RO, Li R, Weber ES, Shen C -
Factors Associated With Hospital Decisions to Purchase Robotic Surgical Systems.
MDM policy & practice 2020 Shen C, Gu D, Klein R, Zhou S, Shih YT, Tracy T, Soybel D, Dillon P -
Assessing the Importance of Factors Associated with Cost-Related Nonadherence to Medication for Older US Medicare Beneficiaries.
Drugs & aging 2019 Gu D, Shen C -
Racial Differences in the Incidence and Survival of Patients With Neuroendocrine Tumors.
Pancreas 2019 Shen C, Gu D, Zhou S, Xu Y, Sarshekeh AM, Halperin D, Shih YT, Yao JC, Dasari A -
Cost-Related Medication Nonadherence and Cost-Reduction Strategies Among Elderly Cancer Survivors with Self-Reported Symptoms of Depression.
Population health management 2019 Gu D, Shen C -
Impact of serious mental illness on the treatment and mortality of older patients with locoregional high-grade (nonmetastatic) prostate cancer: retrospective cohort analysis of 49 985 SEER-Medicare patients diagnosed between 2006 and 2013.
Cancer medicine 2019 Fried DA, Sadeghi-Nejad H, Gu D, Zhou S, He W, Giordano SH, Pentakota SR, Demissie K, Helmer D, Shen C -
Pre-existing Symptoms and Healthcare Utilization Prior to Diagnosis of Neuroendocrine Tumors: A SEER-Medicare Database Study.
Scientific reports 2018 Shen C, Dasari A, Xu Y, Zhou S, Gu D, Chu Y, Halperin DM, Shih YT, Yao JC -
Costs of Cancer Care for Elderly Patients with Neuroendocrine Tumors.
PharmacoEconomics 2018 Shen C, Dasari A, Gu D, Chu Y, Zhou S, Xu Y, Halperin D, Fu S, Yao JC, Shih YT